Pharmacy Times
DECEMBER 20, 2022
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Drug Topics
DECEMBER 22, 2022
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
DECEMBER 22, 2022
Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work.
PhRMA
DECEMBER 19, 2022
Recently, industry leaders, regulators, academics, data partners, and patient advocates gathered in Washington, D.C., to discuss using real-world data and real-world evidence for regulatory decision-making. The discussion explored emerging analytical methodologies to address the challenge of mitigating sources of bias and confounding variables that come up in nearly all sources of real-word data.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
IDStewardship
DECEMBER 22, 2022
In this article a pediatrician puts the 2022-2023 amoxicillin shortage into perspective. . Authored By: Michael Cosimini, M.D. Article Posted 22 December 2022. There is currently a shortage of amoxicillin suspension related to increased demand in the context of a large uptick in pediatric respiratory tract infections. This is a nice time to discuss the valuable role it plays in pediatrics, and alternatives to the medication.
Drug Topics
DECEMBER 22, 2022
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 19, 2022
Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.
STAT
DECEMBER 20, 2022
Lots of people struggle to get enough sleep — and the responsibility for fixing the problem tends to fall on the individual. Experts offer advice like reducing screen time, exercising more, or just going to bed earlier in the evening. But many restless nights can’t be solved with blackout curtains, ear plugs, or other typical suggestions.
Drug Topics
DECEMBER 20, 2022
Understanding the relationship between psoriasis and psoriatic arthritis can help.
PharmaVoice
DECEMBER 22, 2022
New Alzheimer's drugs are poised to change the market — and in preclinical arenas, researchers are learning more and more about the disease.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
DECEMBER 19, 2022
An array of complications may arise associated with treatment of hemophilia A.
pharmaphorum
DECEMBER 19, 2022
A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population. The Engineering and Physical Sciences Research Council (EPSRC) has set aside £400,000 (almost $490,000) for the project, which will help fund work at the Universities of Plymouth, Salford and Stirling, and the Glasgow School of Art.
Drug Topics
DECEMBER 22, 2022
Eli Lilly and Company and Boehringer Ingelheim announced their SGLT2 inhibitor, empagliflozin, was associated with statistically significant reductions in HbA1c relative to placebo therapy among a population of pediatric patients with type 2 diabetes in the DINAMO trial.
PharmaVoice
DECEMBER 19, 2022
A series of small successes showed promise for the future of blood cancer treatments, particularly in the arena of drug combinations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 21, 2022
An anti-cancer vaccine that is now in clinical trials shows promise as a preventative agent. However, experts are unsure when it will be widely available.
Pharmaceutical Technology
DECEMBER 21, 2022
Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year. This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure.
Drug Topics
DECEMBER 22, 2022
CBD is a hot topic on the internet and social media, but large percentages of posts are making therapeutic claims that are not FDA approved or backed by enough research.
PharmaVoice
DECEMBER 21, 2022
For Lightship, increasing patient access to clinical trials is about meeting them where they are — literally.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 20, 2022
Investigators hope findings of study in mice help improve treatment for individuals with acute kidney injury.
Fierce Pharma
DECEMBER 22, 2022
Pfizer, Sanofi settle first California Zantac case slated for trial: report. zbecker. Thu, 12/22/2022 - 12:38.
Drug Topics
DECEMBER 21, 2022
This holiday season, share these tips to and avoid getting—and spreading—COVID-19.
PharmaVoice
DECEMBER 20, 2022
A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.
Pharmacy Times
DECEMBER 19, 2022
Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.
Fierce Healthcare
DECEMBER 20, 2022
From telehealth to Medicare cuts: Here are the health policies in Congress' $1.7T omnibus. rking. Tue, 12/20/2022 - 10:29.
Drug Topics
DECEMBER 23, 2022
Your weekly roundup of the latest news from Drug Topics®.
Pharmaceutical Technology
DECEMBER 23, 2022
Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The companies entered the initial agreement in September last year. This alliance is utilising the Axiomer ribonucleic acid (RNA) editing platform of ProQR to address ailments affecting the liver and nervous system.
Pharmacy Times
DECEMBER 23, 2022
In 10 states, the data showed more than 26% of women had limited accessibility to mammography, primarily in the Rocky Mountains and the South.
European Pharmaceutical Review
DECEMBER 22, 2022
Moderna, Inc. has finalised a strategic partnership with the UK government to establish a state-of-the-art mRNA vaccine research, development, and manufacturing facility in the UK. This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. The Moderna Innovation and Technology Centre (MITC) is intended to provide access to a UK-made supply of COVID-19 jabs.
Drug Topics
DECEMBER 23, 2022
A recent analysis showed that vaccine-associated myopericarditis was rare in adolescents and young adults, and that outcomes were favorable.
STAT
DECEMBER 22, 2022
Sepsis, a deadly overreaction of the immune system to infection, has befuddled clinicians and researchers for decades. Covid-19 made things worse. The early signs and symptoms of sepsis mimic those of both Covid-19 and influenza: fever, chills, dry cough, shortness of breath, fatigue, muscle or body aches, sore throat, nasal congestion, runny nose, and more.
Pharmacy Times
DECEMBER 22, 2022
TD2 remission is defined as a hemoglobin A1C level of less than 6.5% at least 1 year after stopping medication, investigators say.
Fierce Healthcare
DECEMBER 19, 2022
2023 forecast: Amid dwindling COVID relief funds, rural hospitals face a 'fiscal cliff'. agliadkovskaya. Mon, 12/19/2022 - 14:42.
Drug Topics
DECEMBER 23, 2022
Take a look back at our most popular conference coverage for 2022.
Expert insights. Personalized for you.
149 
Let's personalize your content